How Long Should Prophylactic Antibiotics be Prescribed for Permanent Pacemaker Implantations? One Day versus Three

Kuang-Hsing Chiang1, Tze-Fan Chao2, Wen-Shin Lee2

  • 1Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital; ; Division of Cardiology, Department of Internal Medicine; ; Cardiovascular Research Center, Taipei Medical University Hospital; ; Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University;

Abstract

Insights

One-day prophylactic antibiotics are as effective as three-day regimens for preventing pacemaker implantation infections. Pocket hematoma is a key risk factor for infection complications.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Surgical Infections

Background:

  • Pacemaker implantation is a life-saving procedure but carries a risk of infection.
  • Prophylactic antibiotics are used to reduce the incidence of device-related infections.
  • Investigating optimal antibiotic prophylaxis duration and risk factors is crucial for patient safety.

Purpose of the Study:

  • To compare the efficacy of 1-day versus 3-day prophylactic antibiotic regimens in preventing infections after permanent pacemaker implantation.
  • To identify risk factors associated with device-related infections following pacemaker procedures.

Main Methods:

  • A study involving 194 patients undergoing permanent pacemaker (PPM) implantation.
  • Patients received either a 1-day or 3-day course of prophylactic antibiotics.
  • A 3-month follow-up period was conducted to record device-related infections.

Main Results:

  • Five patients (2.6%) experienced infective complications: 1 in the 1-day group and 4 in the 3-day group.
  • No significant difference in infection rates was observed between the 1-day and 3-day antibiotic regimens (1.7% vs. 2.9%, p > 0.99).
  • Pocket hematoma was identified as an independent risk factor for infective complications (OR = 3.14, p = 0.018).

Conclusions:

  • Both 1-day and 3-day prophylactic antibiotic regimens demonstrated similar efficacy in preventing PPM-related infections.
  • Pocket hematoma is a significant risk factor, warranting consideration for extended antibiotic treatment in affected patients.
  • A 1-day antibiotic prophylaxis course may be sufficient, potentially reducing hospitalization duration.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
424
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
325
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
555
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
83
Holter Monitor: 24-Hour Monitoring01:23

Holter Monitor: 24-Hour Monitoring

Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
4.1K
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
315